Piperacillin + Tazobactam

DRUG3 trials

Sponsors

Institute of Liver and Biliary Sciences, India, Bassett Healthcare, IRCCS Azienda Ospedaliero-Universitaria di Bologna

Conditions

Acute Kidney InjuryAntibiotic ProphylaxisCRE ColonizationCarbapenem-resistant EnterobacteralesInfectionLiver TransplantPostoperative InfectionSepsis

Phase 3

Targeted Versus Standard Peri-operative Antibiotic Prophylaxis in Patients Colonized With Carbapenemase Producing Enterobacterales Undergoing Liver Transplantation

Not yet recruitingNCT07759453

IRCCS Azienda Ospedaliero-Universitaria di BolognaLiver Transplant, Carbapenem-resistant Enterobacterales, CRE Colonization

Start: 2026-10-01End: 2029-09-30Target: 168Updated: 2026-08-12

Phase 4

The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS)

RecruitingNCT07556107

Bassett HealthcareInfection, Acute Kidney Injury, Sepsis

Start: 2026-08-17End: 2028-12-31Target: 852Updated: 2026-08-18

Unknown Phase

Comparison of 9 Doses vs 3 Doses of Post Operative Antibiotics in Live Liver Donors

CompletedNCT03765645

Institute of Liver and Biliary Sciences, IndiaAntibiotic Prophylaxis, Postoperative Infection

Start: 2018-10-04End: 2020-08-31Updated: 2021-02-04